The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Vink, Mark, Vink-Niese, Alexandra · Diseases (Basel, Switzerland) · 2023 · DOI
Quick Summary
This study examined whether a German health institute's recommendation for graded exercise therapy (GET) and cognitive behavioral therapy (CBT) to treat ME/CFS was supported by good evidence. The researchers found serious problems with the studies being used to make this recommendation, including weak study designs, reliance on patient reports rather than objective measurements, and inclusion of people who may not have had ME/CFS. They concluded these treatments should not be recommended based on the available evidence.
Why It Matters
This analysis is critical for ME/CFS patients because it demonstrates that major health policy recommendations may be based on flawed evidence, potentially leading to harm if patients pursue treatments that have not been proven safe or effective. Understanding the quality of evidence underlying clinical guidelines helps patients and clinicians make informed decisions and highlights the need for rigorous research meeting modern methodological standards.
Observed Findings
The cited studies showed no objective improvement on six-minute walk test performance despite IQWiG's recommendation
Many patients included in the studies did not meet proper ME/CFS diagnostic criteria, particularly regarding post-exertional malaise
Treatment adherence was very low across the reviewed studies
Objective outcome measures (step test, occupational status, benefit status) showed null effects that were not analyzed by IQWiG
The studies lacked adequate reporting on safety outcomes
Inferred Conclusions
The reviewed evidence does not support IQWiG's recommendation for GET and CBT in ME/CFS treatment
Methodological flaws in trial design, patient selection, and outcome measurement undermine confidence in positive findings
Policy recommendations should be based on objective clinical outcomes and adequate safety data, neither of which were demonstrated in the reviewed studies
Disparities between IQWiG's conclusions and NICE's updated guidelines suggest inconsistent interpretation of existing evidence across health systems
Remaining Questions
What would constitute adequate evidence for evaluating treatments in ME/CFS, given the challenges in defining homogeneous patient populations and measuring objective outcomes?
What This Study Does Not Prove
This critique does not prove that GET and CBT are ineffective for all patients or in all contexts, only that the specific evidence IQWiG cited contains significant methodological limitations. It does not establish what treatments would be effective alternatives for ME/CFS, nor does it definitively rule out potential benefit in specific patient subgroups, though it does suggest current evidence cannot support such claims.
Why did different health institutes (IQWiG vs. NICE) reach opposite conclusions when reviewing similar evidence?
What alternative research designs and outcome measures would be needed to properly evaluate behavioral and physical interventions in ME/CFS?
How should post-exertional malaise and exertion intolerance be properly operationalized and measured in clinical trials to ensure patient selection and safety monitoring?